Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 138

1.

The relation of HLA genotype to hepatitis C viral load and markers of liver fibrosis in HIV-infected and HIV-uninfected women.

Kuniholm MH, Gao X, Xue X, Kovacs A, Marti D, Thio CL, Peters MG, Greenblatt RM, Goedert JJ, Cohen MH, Minkoff H, Gange SJ, Anastos K, Fazzari M, Young MA, Strickler HD, Carrington M.

J Infect Dis. 2011 Jun 15;203(12):1807-14. doi: 10.1093/infdis/jir192.

2.

Assessing mortality in women with hepatitis C virus and HIV using indirect markers of fibrosis.

Bambha K, Pierce C, Cox C, French AL, Tien PC, Sharp GB, Augenbraun M, Glesby MJ, Villacres MC, Plankey M, Strickler HD, Gange SJ, Peters MG.

AIDS. 2012 Mar 13;26(5):599-607. doi: 10.1097/QAD.0b013e32834fa121.

3.

Progression of liver fibrosis among injection drug users with chronic hepatitis C.

Wilson LE, Torbenson M, Astemborski J, Faruki H, Spoler C, Rai R, Mehta S, Kirk GD, Nelson K, Afdhal N, Thomas DL.

Hepatology. 2006 Apr;43(4):788-95.

PMID:
16557548
4.

Liver fibrosis in patients with chronic hepatitis C and persistently normal liver enzymes: influence of HIV infection.

Martin-Carbonero L, de Ledinghen V, Moreno A, Maida I, Foucher J, Barreiro P, Romero M, Satta G, Garcia-Samaniego J, Gonzalez-Lahoz J, Soriano V.

J Viral Hepat. 2009 Nov;16(11):790-5. doi: 10.1111/j.1365-2893.2009.01133.x.

PMID:
19413693
5.

Noninvasive serum fibrosis markers for screening and staging chronic hepatitis C virus patients in a large US cohort.

Holmberg SD, Lu M, Rupp LB, Lamerato LE, Moorman AC, Vijayadeva V, Boscarino JA, Henkle EM, Gordon SC; Chronic Hepatitis Cohort Study (CHeCS) Investigators..

Clin Infect Dis. 2013 Jul;57(2):240-6. doi: 10.1093/cid/cit245.

PMID:
23592832
6.

Effect of human leukocyte antigen class I and II alleles on hepatitis C viral load among chronic hepatitis C patients in Southern Taiwan.

Tseng KC, Tseng CW, Hsieh YH, Chang CK, Lai NS, Hung TH, Chang TT.

Hum Immunol. 2013 Aug;74(8):978-82. doi: 10.1016/j.humimm.2013.04.023.

PMID:
23628398
7.

Evaluation of liver fibrosis: concordance analysis between noninvasive scores (APRI and FIB-4) evolution and predictors in a cohort of HIV-infected patients without hepatitis C and B infection.

Mendeni M, Focà E, Gotti D, Ladisa N, Angarano G, Albini L, Castelnuovo F, Carosi G, Quiros-Roldan E, Torti C.

Clin Infect Dis. 2011 May;52(9):1164-73. doi: 10.1093/cid/cir071.

PMID:
21467023
8.

Predictors of liver fibrosis in HIV-infected patients with chronic hepatitis C virus (HCV) infection: assessment using transient elastometry and the role of HCV genotype 3.

Barreiro P, Martín-Carbonero L, Núñez M, Rivas P, Morente A, Simarro N, Labarga P, González-Lahoz J, Soriano V.

Clin Infect Dis. 2006 Apr 1;42(7):1032-9.

PMID:
16511772
9.

Enhanced liver fibrosis marker as a noninvasive predictor of mortality in HIV/hepatitis C virus-coinfected women from a multicenter study of women with or at risk for HIV.

Peters MG, Bacchetti P, Boylan R, French AL, Tien PC, Plankey MW, Glesby MJ, Augenbraun M, Golub ET, Karim R, Parkes J, Rosenberg W.

AIDS. 2016 Mar 13;30(5):723-9. doi: 10.1097/QAD.0000000000000975.

PMID:
26595542
10.

High plasma CXCL10 levels are associated with HCV-genotype 1, and higher insulin resistance, fibrosis, and HIV viral load in HIV/HCV coinfected patients.

Berenguer J, Fernandez-Rodríguez A, Jimenez-Sousa MA, Cosín J, Zarate P, Micheloud D, López JC, Miralles P, Catalán P, Resino S.

Cytokine. 2012 Jan;57(1):25-9. doi: 10.1016/j.cyto.2011.10.020.

PMID:
22136974
11.

Histological features and HLA class II alleles in hepatitis C virus chronically infected patients with persistently normal alanine aminotransferase levels.

Renou C, Halfon P, Pol S, Cacoub P, Jouve E, Bronowicki JP, Arpurt JP, Rifflet H, Picon M, Causse X, Canva V, Denis J, Tran A, Bourliére M, Ouzan D, Pariente A, Dantin S, Alric L, Cartier V, Reville M, Caillat-Zucman S.

Gut. 2002 Oct;51(4):585-90.

12.

Change in fibrosis score as a predictor of mortality among HIV-infected patients with viral hepatitis.

Jain MK, Seremba E, Bhore R, Dao D, Joshi R, Attar N, Yuan HJ, Lee WM.

AIDS Patient Care STDS. 2012 Feb;26(2):73-80. doi: 10.1089/apc.2011.0191.

13.

Validation and comparison of simple noninvasive models for the prediction of liver fibrosis in chronic hepatitis C.

Amorim TG, Staub GJ, Lazzarotto C, Silva AP, Manes J, Ferronato Mda G, Shiozawa MB, Narciso-Schiavon JL, Dantas-Correa EB, Schiavon Lde L.

Ann Hepatol. 2012 Nov-Dec;11(6):855-61.

14.

Specific human leukocyte antigen class I and II alleles associated with hepatitis C virus viremia.

Kuniholm MH, Kovacs A, Gao X, Xue X, Marti D, Thio CL, Peters MG, Terrault NA, Greenblatt RM, Goedert JJ, Cohen MH, Minkoff H, Gange SJ, Anastos K, Fazzari M, Harris TG, Young MA, Strickler HD, Carrington M.

Hepatology. 2010 May;51(5):1514-22. doi: 10.1002/hep.23515.

15.

Does hepatitis C viremia or genotype predict the risk of mortality in individuals co-infected with HIV?

Rockstroh JK, Peters L, Grint D, Soriano V, Reiss P, Monforte Ad, Beniowski M, Losso MH, Kirk O, Kupfer B, Mocroft A; EuroSIDA in EuroCoord..

J Hepatol. 2013 Aug;59(2):213-20. doi: 10.1016/j.jhep.2013.04.005.

PMID:
23583272
16.

Documented rapid course of hepatic fibrosis between two biopsies in patients coinfected by HIV and HCV despite high CD4 cell count.

Bonnard P, Lescure FX, Amiel C, Guiard-Schmid JB, Callard P, Gharakhanian S, Pialoux G.

J Viral Hepat. 2007 Nov;14(11):806-11.

PMID:
17927617
17.

Correlation of transient elastography with APRI and FIB-4 in a cohort of patients with congenital bleeding disorders and HCV or HIV/HCV coinfection.

Vidovic N, Lochowsky RS, Goldmann G, Rockstroh J, Wasmuth JC, Spengler U, Sauerbruch T, Lammert F, Oldenburg J, Grünhage F.

Haemophilia. 2010 Sep 1;16(5):778-85. doi: 10.1111/j.1365-2516.2010.02204.x.

PMID:
20331759
18.

Advanced liver fibrosis by transient elastography, fibrosis 4, and alanine aminotransferase/platelet ratio index among Asian hepatitis C with and without human immunodeficiency virus infection: role of vitamin D levels.

Avihingsanon A, Jitmitraparp S, Tangkijvanich P, Ramautarsing RA, Apornpong T, Jirajariyavej S, Putcharoen O, Treeprasertsuk S, Akkarathamrongsin S, Poovorawan Y, Matthews GV, Lange JM, Ruxrungtham K; HIV-NAT125 study team..

J Gastroenterol Hepatol. 2014 Sep;29(9):1706-14. doi: 10.1111/jgh.12613.

PMID:
24730732
19.

Association between HLA class II alleles and protection from or susceptibility to chronic hepatitis C.

Zavaglia C, Martinetti M, Silini E, Bottelli R, Daielli C, Asti M, Airoldi A, Salvaneschi L, Mondelli MU, Ideo G.

J Hepatol. 1998 Jan;28(1):1-7.

PMID:
9537846
20.
Items per page

Supplemental Content

Support Center